Asahi Kasei And Pfizer To Co-Promote Recomodulin In Japan From November
This article was originally published in PharmAsia News
Executive Summary
Asahi Kasei and Pfizer have agreed to start co-promoting the disseminated intravascular coagulation drug Recomodulin (thrombomodulin alpha) sold by Asahi Kasei in Japan starting in November.